LAPSE:2019.0863v1
Published Article
LAPSE:2019.0863v1
Using a Microfluidics System to Reproducibly Synthesize Protein Nanoparticles: Factors Contributing to Size, Homogeneity, and Stability
Courtney van Ballegooie, Alice Man, Irene Andreu, Byron D. Gates, Donald Yapp
July 31, 2019
The synthesis of Zein nanoparticles (NPs) using conventional methods, such as emulsion solvent diffusion and emulsion solvent evaporation, is often unreliable in replicating particle size and polydispersity between batch-to-batch syntheses. We have systematically examined the parameters for reproducibly synthesizing Zein NPs using a Y-junction microfluidics chip with staggered herringbone micromixers. Our results indicate that the total flow rate of the fluidics system, relative flow rate of the aqueous and organic phase, concentration of the base material and solvent, and properties of the solvent influence the polydispersity and size of the NPs. Trends such as increasing the total flow rate and relative flow rate lead to a decrease in Zein NP size, while increasing the ethanol and Zein concentration lead to an increase in Zein NP size. The solvent property that was found to impact the size of the Zein NPs formed the most was their hydropathy. Solvents that had a hydropathy index most similar to that of Zein formed the smallest Zein NPs. Synthesis consistency was confirmed within and between sample batches. Stabilizing agents, such as sodium caseinate, Tween 80, and Pluronic F-68, were incorporated using the microfluidics system, necessary for in vitro and in vivo use, into Zein-based NPs.
Keywords
delivery systems, microfluidic coprecipitation, pharmaceutics, syringe pump, zein nanoparticles
Subject
Suggested Citation
van Ballegooie C, Man A, Andreu I, Gates BD, Yapp D. Using a Microfluidics System to Reproducibly Synthesize Protein Nanoparticles: Factors Contributing to Size, Homogeneity, and Stability. (2019). LAPSE:2019.0863v1
Author Affiliations
van Ballegooie C: Experimental Therapeutics, BC Cancer, Vancouver, BC V5Z 1L3, Canada; Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
Man A: Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
Andreu I: Experimental Therapeutics, BC Cancer, Vancouver, BC V5Z 1L3, Canada; Department of Chemistry, Simon Fraser University, Burnaby, BC V5A 1S6, Canada
Gates BD: Department of Chemistry, Simon Fraser University, Burnaby, BC V5A 1S6, Canada [ORCID]
Yapp D: Experimental Therapeutics, BC Cancer, Vancouver, BC V5Z 1L3, Canada; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z4, Canada [ORCID]
[Login] to see author email addresses.
Journal Name
Processes
Volume
7
Issue
5
Article Number
E290
Year
2019
Publication Date
2019-05-15
Published Version
ISSN
2227-9717
Version Comments
Original Submission
Other Meta
PII: pr7050290, Publication Type: Journal Article
Record Map
Published Article

LAPSE:2019.0863v1
This Record
External Link

doi:10.3390/pr7050290
Publisher Version
Download
Files
[Download 1v1.pdf] (4.8 MB)
Jul 31, 2019
Main Article
License
CC BY 4.0
Meta
Record Statistics
Record Views
431
Version History
[v1] (Original Submission)
Jul 31, 2019
 
Verified by curator on
Jul 31, 2019
This Version Number
v1
Citations
Most Recent
This Version
URL Here
https://psecommunity.org/LAPSE:2019.0863v1
 
Original Submitter
Calvin Tsay
Links to Related Works
Directly Related to This Work
Publisher Version